← SynDRA
ACEBUTOLOL
SynDRA canonical compound SYN0001289 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | ADRB1 |
|---|
| Mechanism of action | Adrenergic receptor antagonist |
|---|
| Indication | hypertension | ventricular arrhythmias |
|---|
| Disease area | cardiology |
|---|
All known targets
Mechanisms of action (all sources)
- Adrenergic receptor antagonist
- ADRB1 ANTAGONIST
- Beta-1 adrenergic receptor antagonist
Drug classes
- Adrenergic beta-Antagonists
- beta-Adrenergic Blocker
- Adrenergic Agents
- Adrenergic Antagonists
- Adrenergic beta-1 Receptor Antagonists
- Anti-Arrhythmia Agents
- Antihypertensive Agents
- Cardiovascular Agents
- Neurotransmitter Agents
- Peripheral Nervous System Agents
- Sympathomimetics
ATC classes
- C07A · BETA BLOCKING AGENTS
- BETA BLOCKING AGENTS AND THIAZIDES
Cross-references
Synonyms
- IL-17803A
- acebutolol HCl
- acebutolol hydrochloride
- (RS)-Acebutolol
- (+/-)-Acebutolol
- dl-Acebutolol
- C07AB04
- Acebrutololum
- Acebutololo
- Acebutololum
- Acetobutolol
- Neptal
- Prent
- Sectral
- Acebutolol HCL
- RP 21823
- Acebrutololum [INN-Latin]
- Acebutololum [INN-Latin]
- Acetobutolol [INN-Spanish]
- Dl-Acebutolol
- M & B 17803A
- Prent (TN)
- Sectral (TN)
- Acebutolol (USAN/INN)
- Acebutolol [USAN:INN:BAN]
- M&B-17803 A
- N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide
- N-[3-acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide
- N-[3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]butanamide
- N-{3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}butanamide
- (+-)-3'-Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide
- (+-)-Acebutolol
- (+-)-N-(3-Acetyl-4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)butanamide
- 1-(2-Acetyl-4-n-butyramidophenoxy)-2-hydroxy-3-isopropylaminopropane
- 3'-(Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide
- 3'-Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide
- 3'-Acetyl-4'-(2-hydroxy-3-isopropylaminopropoxy)butyranilid
- 5'-Butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone
Reported adverse events
- Agranulocytosis
- Depression
- Dizziness
- Erythema
- Fatigue
- Nausea
- Rash
- Abnormal dreams
- Arthralgia
- Constipation
- Cough
- Dyspepsia
Look up ACEBUTOLOL in the interactive SynDRA portal →